The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis

The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis

Background: CD44 is widely used as a putative cancer stem cells (CSCs) marker for colorectal cancer (CRC). However, the prognostic role of CD44 in CRC remains controversial.Methods: We performed a systematic review and meta-analysis to evaluate the association of various CD44 isoforms and overall su...

Full description

Bibliographic Details
Main Authors: Zhenpeng Wang, Yufei Tang, Lei Xie, Aiping Huang, Chunchun Xue, Zhen Gu, Kaiqiang Wang, Shaoqi Zong
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Oncology
Subjects:
CD44
variant
colorectal cancer
survival
prognosis
meta-analysis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00309/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00309/full

Similar Items